Abstract
PCV53 Cost Comparison of Low Dose Dabigatran over Other NOVEL ORAL Anticoagulants for the Treatment of Patients with NON-Valvular Atrial Fibrillation WHO HAD NOT Previously Taken an ORAL Anticoagulant in Greece.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have